The World Set a 60% Survival Target for Kids With Cancer - and Then Awkwardly Realized It Might Be Too Easy

Somewhere in a conference room in 2018, the World Health Organization gathered some very serious people around a very serious table and declared that by 2030, at least 60% of children diagnosed with cancer worldwide should survive five years. It was ambitious. It was bold. It was - according to the largest study ever conducted on the subject - possibly not ambitious enough.

Counting Every Kid: The CONCORD-4 Story

The CONCORD programme has been quietly doing what epidemiologists do best - collecting enormous amounts of data and making the rest of us feel statistically illiterate. Now in its fourth cycle, the programme just dropped what can only be described as the phone book of childhood cancer survival: individual medical records for 613,021 children from 307 cancer registries across 68 countries, spanning three decades of diagnoses from 1990 to 2019 (Allemani et al., 2026).

To put that in perspective, that's more children than the population of Luxembourg. Each one a data point that represents a kid, a family, and a healthcare system either rising to the occasion or failing spectacularly.

The Cancer Survival Index: Finally, a Report Card That Actually Works

One of the study's neatest tricks is the invention of something called the Cancer Survival Index (CSI) - a single number that summarizes how well a country is doing at keeping children with cancer alive, adjusted for the messy reality that different countries see different types of cancer at different rates.

Think of it as a grade point average for national healthcare systems, except nobody gets extra credit for effort, and the test is whether children survive. The CSI standardizes across age, sex, and cancer subtype, which means you can actually compare Denmark to Colombia without someone shouting "but they have different cancer profiles!" at a conference podium.

The Good, the Improving, and the Unconscionable

Here's where irony enters the chat. The WHO set 60% as the target. Most high-income countries are already sitting pretty above 80%. Upper-middle-income countries? Mostly in the 60-80% range. So the target that was supposed to be a stretch goal is, for a large chunk of the participating world, already yesterday's news.

But - and this is the kind of "but" that should keep you up at night - the five lower-middle-income countries that participated hovered around 50-60%, and low-income countries largely couldn't even contribute data because their cancer registries barely exist. When a child in Kenya is initially misdiagnosed with malaria nearly 70% of the time before anyone thinks to check for leukemia, "60% survival" isn't an underwhelming target. It's a fantasy.

The Geography Lottery Nobody Asked to Play

The survival gap between rich and poor nations is less a gap and more a canyon with a river of preventable deaths running through it. Acute lymphoblastic leukemia - the most common childhood cancer - sees survival rates above 90% in high-income countries. In many low- and middle-income countries, it's below 50%. Same disease. Same biology. Wildly different outcomes based entirely on postal code (Ehrlich et al., 2023).

Treatment abandonment affects roughly one in seven children with cancer globally, driven by poverty, distance to care, and the entirely rational but devastating conclusion that treatment will bankrupt a family before it cures anyone (Atun et al., 2025). Bangladesh has two cancer centers for an estimated 9,000 pediatric cancer cases per year. Two. That's not a healthcare system; that's a bottleneck with a waiting room.

So Where Does This Leave Us?

The CONCORD-4 results are simultaneously the best and worst news in pediatric oncology. Best: we now have a standardized, global metric to track progress, and the trend lines in most participating countries point upward. Worst: the countries most desperately needing improvement are largely invisible in the data because they lack the infrastructure to count their own sick children, let alone treat them.

The WHO's 60% target was always meant to be a floor, not a ceiling. But if the countries already above it start congratulating themselves while 90% of the world's childhood cancers occur in places that can't reliably diagnose them (Smith et al., 2024), we'll have built a very impressive scorecard for a game that most of the world's children never got to play.

References

1. Allemani C, Di Carlo V, Ssenyonga N, et al. Progress towards the WHO Global Initiative for Childhood Cancer target of 60% 5-year survival for all childhood cancers combined, 1990-2019 (CONCORD-4). The Lancet. 2026. DOI: 10.1016/S0140-6736(26)00189-3. PMID: 41905383

2. Ehrlich BS, McNeil MJ, Pham LTD, et al. Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet Oncology. 2023;24(9):967-977. DOI: 10.1016/S1470-2045(23)00318-2

3. Smith ER, Cotache-Condor C, Leraas H, et al. Towards attainment of the 2030 goal for childhood cancer survival for the World Health Organization Global Initiative for Childhood Cancer. PLOS Global Public Health. 2024. DOI: 10.1371/journal.pgph.0002530. PMCID: PMC11332931

4. Atun R, Bhakta N, Denburg A, Rodriguez-Galindo C, et al. National data for global 2030 targets for childhood cancer. The Lancet. 2025. DOI: 10.1016/S0140-6736(25)02468-7

5. Allemani C, Azevedo e Silva G, Mathur P, Coleman MP. The CONCORD-Lancet Global Commission on Cancer. The Lancet. 2024;404(10450):320-322. DOI: 10.1016/S0140-6736(24)01345-X

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.